5. Conclusions
critically ill, ill
CRITICALLY ILL
The administration of NAC manages to improve the clinical and analytical response of seriously ill patients with COVID-19 compared to the control group. NAC is able to stop the decrease in glutathione concentrations. Therefore, the administration of NAC in critically ill patients with COVID-19 could be assessed based on the need for quick and agile intervention through monitoring and follow-up in the ICU from the beginning of the stay to prevent and correct possible alterations and improve prognosis.